Key DNA complex connected to PARP inhibitor cancer-drug resistance discovered

June 9, 2025

Scientists at The University of Texas Health Science Center at San Antonio (UT Health San Antonio) have made one of the most important discoveries to date in the study and treatment of BRCA1-deficient cancers and drug resistance. Approximately one in 300 Americans have a pathogenic mutation in the BRCA1 or BRCA2 gene, placing them at an […]


CPRIT awards UT Health San Antonio $3.4 million to increase HPV vaccination rates in Bexar County, develop transformative technologies targeting drug-resistant cancers

June 2, 2025

  The University of Texas Health Science Center at San Antonio (UT Health San Antonio) received $3,395,970 in new academic research and prevention awards as part of the latest $98 million funding round announced on May 21 by the Cancer Research Prevention Institute of Texas (CPRIT). The state agency, which focuses on funding evidence-based cancer […]




Making groundbreaking discoveries with local and global impact

May 29, 2025

In the past five years, UT Health San Antonio has conducted more than 600 clinical research projects with one goal in mind — making lives better for people in San Antonio, Texas and beyond through innovative solutions to today’s most challenging health problems.

a woman stands in front of a screen of brain images.



UT Health San Antonio scientists pioneer drug-discovery breakthrough for large and polar drugs

April 18, 2025

Discovery of chemical endocytosis could redefine precision medicine A team of scientists, notably Zhengyu Wang, PhD, assistant professor in the department of pharmacology and the Barshop Institute, led by Hong-yu Li, PhD, professor of medicinal chemistry and chemical biology with the department of pharmacology and the Barshop Institute at The University of Texas Health Science […]